Pfizer forecasts higher COVID-19 vaccine, pill sales in 2022, but analysts expected more –…
Pfizer Inc. forecast $54 billion in full-year sales of its COVID-19 vaccine and antiviral pill on Tuesday that fell short of lofty Wall Street estimates, sending its shares down four per cent.
Although Pfizer raised its forecast for…